Digital Opinion Leaders: Unlocking New Engagement Opportunities
How to harness the growing influence of Digital Opinion Leaders
Why should pharma engage digital opinion leaders (DOLs)? With their extensive online networks, the influence of DOLs can be wide, such as effectively engaging with underserved or rare disease communities. DOLs represent an untapped opportunity for pharma to better understand patients, target marketing and influence payers—but only if operational challenges such as identifying credible DOLs and regulatory compliance can be overcome.
Companies
Sanofi, Gilead Sciences, Google, Meta, HealthTree Foundation, Indegene, Leukemia and Lymphoma Society, Multiple Myeloma Research Foundation
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Untapped potential of DOLs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Two audiences in one
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Engaging payers
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Specificity of reach
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Augmented engagement
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Key challenges
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- The future of DOLs in pharma
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook